Inger Hagerman

1.8k total citations
46 papers, 1.2k citations indexed

About

Inger Hagerman is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Inger Hagerman has authored 46 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Inger Hagerman's work include Heart Failure Treatment and Management (12 papers), Heart Rate Variability and Autonomic Control (8 papers) and Air Quality and Health Impacts (5 papers). Inger Hagerman is often cited by papers focused on Heart Failure Treatment and Management (12 papers), Heart Rate Variability and Autonomic Control (8 papers) and Air Quality and Health Impacts (5 papers). Inger Hagerman collaborates with scholars based in Sweden, Denmark and United States. Inger Hagerman's co-authors include Hans Persson, Ewa Hägglund, Patrik Lyngå, Ida Haugen Löfman, Tomas Jernberg, Christer Sylvén, Michael Melin, Jacek Nowak, Margareta Berglund and Claire Anne Eriksen and has published in prestigious journals such as PLoS ONE, European Heart Journal and The Journal of the Acoustical Society of America.

In The Last Decade

Inger Hagerman

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inger Hagerman Sweden 17 657 192 157 141 131 46 1.2k
Nico Dragano Germany 18 796 1.2× 421 2.2× 202 1.3× 108 0.8× 133 1.0× 31 1.7k
Ulf Näslund Sweden 25 1.1k 1.7× 333 1.7× 381 2.4× 93 0.7× 102 0.8× 99 2.0k
Elizabeth Wilkins United Kingdom 8 400 0.6× 138 0.7× 73 0.5× 48 0.3× 197 1.5× 12 1.3k
Blake Taylor United States 13 207 0.3× 369 1.9× 185 1.2× 81 0.6× 105 0.8× 23 1.4k
Jürgen H. Prochaska Germany 22 559 0.9× 169 0.9× 126 0.8× 64 0.5× 26 0.2× 92 1.4k
Quan Huynh Australia 21 712 1.1× 142 0.7× 60 0.4× 38 0.3× 98 0.7× 76 1.3k
Kentaro Kamiya Japan 25 1.1k 1.7× 367 1.9× 204 1.3× 114 0.8× 62 0.5× 205 2.4k
José Augusto Soares Barreto-Filho Brazil 15 1.0k 1.5× 187 1.0× 103 0.7× 101 0.7× 206 1.6× 53 1.6k
Jennifer J. Majersik United States 27 293 0.4× 151 0.8× 507 3.2× 38 0.3× 132 1.0× 107 2.4k
Lola A. Coke United States 11 2.3k 3.5× 269 1.4× 482 3.1× 182 1.3× 177 1.4× 45 3.3k

Countries citing papers authored by Inger Hagerman

Since Specialization
Citations

This map shows the geographic impact of Inger Hagerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Hagerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Hagerman more than expected).

Fields of papers citing papers by Inger Hagerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger Hagerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Hagerman. The network helps show where Inger Hagerman may publish in the future.

Co-authorship network of co-authors of Inger Hagerman

This figure shows the co-authorship network connecting the top 25 collaborators of Inger Hagerman. A scholar is included among the top collaborators of Inger Hagerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inger Hagerman. Inger Hagerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hägglund, Ewa, Anna Strömberg, Inger Hagerman, & Patrik Lyngå. (2019). Theory Testing of Patient Perspectives Using a Mobile Health Technology System in Heart Failure Self-care. The Journal of Cardiovascular Nursing. 34(6). 448–453. 11 indexed citations
2.
Melin, Michael, Inger Hagerman, Adrian Gonon, Thomas Gustafsson, & Eric Rullman. (2016). Variability in Physical Activity Assessed with Accelerometer Is an Independent Predictor of Mortality in CHF Patients. PLoS ONE. 11(4). e0153036–e0153036. 21 indexed citations
3.
Desta, Liyew, Tomas Jernberg, Ida Haugen Löfman, et al.. (2015). Incidence, Temporal Trends, and Prognostic Impact of Heart Failure Complicating Acute Myocardial Infarction. JACC Heart Failure. 3(3). 234–242. 132 indexed citations
4.
Hägglund, Ewa, Patrik Lyngå, Bengt Ullman, et al.. (2015). Patient-centred home-based management of heart failure. Scandinavian Cardiovascular Journal. 49(4). 193–199. 91 indexed citations
5.
Sahlén, Anders, Andreas Rück, Inger Hagerman, et al.. (2013). Relation between N-terminal pro-brain natriuretic peptide levels and response to enhanced external counterpulsation in chronic angina pectoris. Coronary Artery Disease. 25(1). 45–51. 2 indexed citations
6.
Lyngå, Patrik, Hans Persson, Ewa Hägglund, et al.. (2012). Weight Monitoring in Patients with Severe Heart Failure (WISH). A Randomized Controlled Trial. European Journal of Heart Failure. 14(4). 438–444. 108 indexed citations
7.
Dellgren, Göran, Odd Geiran, Karl Lemström, et al.. (2012). Three Decades of Heart Transplantation in Scandinavia: Long-Term Follow-Up. European Journal of Heart Failure. 15(3). 308–315. 39 indexed citations
8.
Tydén, Gunnar, Inger Hagerman, Karl‐Henrik Grinnemo, et al.. (2012). Intentional ABO-incompatible heart transplantation: A case report of 2 adult patients. The Journal of Heart and Lung Transplantation. 31(12). 1307–1310. 16 indexed citations
9.
Sigurdardottir, V., Øystein Bjørtuft, Hans Eiskjær, et al.. (2012). Long-term follow-up of lung and heart transplant recipients with pre-transplant malignancies. The Journal of Heart and Lung Transplantation. 31(12). 1276–1280. 28 indexed citations
10.
Bohgard, Mats, Jörn Nielsen, Inger Hagerman, et al.. (2011). Physiological effects on humans when exposed to nanometer sized airborne particles in well controlled chamber studies. Lund University Publications (Lund University). 3. 2115–2116. 1 indexed citations
11.
Alvestrand, Anders, Ingrid Ledebo, Inger Hagerman, et al.. (2011). Left Ventricular Hypertrophy in Incident Dialysis Patients Randomized to Treatment with Hemofiltration or Hemodialysis: Results from the ProFil Study. Blood Purification. 32(1). 21–29. 11 indexed citations
12.
Fux, Thomas, Peter Svenarud, Karl‐Henrik Grinnemo, et al.. (2010). Extracorporeal Membrane Oxygenation as a Rescue of Intractable Ventricular Fibrillation and Bridge to Heart Transplantation. European Journal of Heart Failure. 12(3). 301–304. 13 indexed citations
13.
Hagerman, Inger, Raija Tyni‐Lenné, & A. Gordon. (2004). Outcome of exercise training on the long-term burden of hospitalisation in patients with chronic heart failure. A restrospective study. International Journal of Cardiology. 98(3). 487–491. 7 indexed citations
14.
Hagerman, Inger, Gundars Rasmanis, Vanja Blomkvist, et al.. (2004). Influence of intensive coronary care acoustics on the quality of care and physiological state of patients. International Journal of Cardiology. 98(2). 267–270. 130 indexed citations
15.
Sylvén, Christer, et al.. (2001). Oscillation of pain intensity during adenosine infusion. Relationship to β-endorphin and sympathetic tone. Neuroreport. 12(8). 1571–1575. 4 indexed citations
16.
Jansson, Kjell, et al.. (1999). The effects of metoprolol and captopril on heart rate variability in patients with idiopathic dilated cardiomyopathy. Clinical Cardiology. 22(6). 397–402. 17 indexed citations
17.
Hagerman, Inger, et al.. (1996). Beat-to-Beat QRS Amplitude Variability during Dobutamine Infusion in Patients with Coronary Artery Disease. Cardiology. 87(2). 161–168. 7 indexed citations
18.
Sylvén, Christer, et al.. (1995). Platelet and leukocyte activation after myocardial infarction. European Heart Journal. 16(12). 1800–1806. 11 indexed citations
19.
Sylvén, Christer, et al.. (1994). Variance ecg detection of coronary artery disease—a comparison with exercise stress test and myocardial scintigraphy. Clinical Cardiology. 17(3). 132–140. 11 indexed citations
20.
Chen, Jihong, Inger Hagerman, Kurt Bergström, et al.. (1993). Streptokinase, but not tissue plasminogen activator, attenuates platelet aggregation in patients with acute myocardial infarction. Journal of Internal Medicine. 234(5). 513–519. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nico Dragano Breakdown of academic impact, for papers by Ulf Näslund Breakdown of academic impact, for papers by Elizabeth Wilkins Breakdown of academic impact, for papers by Blake Taylor Breakdown of academic impact, for papers by Jürgen H. Prochaska Breakdown of academic impact, for papers by Quan Huynh Breakdown of academic impact, for papers by Kentaro Kamiya Breakdown of academic impact, for papers by José Augusto Soares Barreto-Filho Breakdown of academic impact, for papers by Jennifer J. Majersik Breakdown of academic impact, for papers by Lola A. Coke
Rankless by CCL
2026